🇺🇸 FDA
Pipeline program

Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection

20250527IIT0060

Unknown small_molecule completed

Quick answer

Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection for Dexmedetomidine Induced Sedation is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Dexmedetomidine Induced Sedation
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials